Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1109 of 5804
-
Electric pulses zapping liver tumors: new hope for colorectal cancer patients?
Disease control Not yet recruitingProcedural data will be recorded from patients with liver metastases from colorectal cancer who have received at least one course of systemic chemotherapy and who have been assessed by an appropriately constituted MDT (or equivalent) as appropriate to receive irreversible electro…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for hard-to-treat lymphoma: experimental drug enters phase 2 trial
Disease control Not yet recruitingThe objective of this phase II study is to evaluate the efficacy and safety of BR101801 in patients with peripheral T-cell lymphoma(PTCL).
Phase: PHASE2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Weekly shot could replace daily needles for short stature kids
Disease control Recruiting nowThis study is a randomized, open-label, active controlled, parallel group study comparing the efficacy and safety of once weekly Somatrogon to daily Growth Hormone (Genotropin) in pre-pubertal children with short stature either born Small for Gestational Age (SGA) or with Idiopat…
Phase: PHASE3 • Sponsor: Rabin Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug aims to fix Immunotherapy's blood problems in lung cancer
Disease control Not yet recruitingThis study is a single-arm clinical trial designed to evaluate the safety and efficacy of golidocitinib in patients with refractory, immune-related hematologic toxicity in advanced lung cancer.
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can brain zaps help restore vision after stroke?
Symptom relief Recruiting nowHomonymous visual field defects (HVFDs) after acquired brain injuries affect daily life by impairing reading, navigation, and social activities, often impacting anxiety and depression. Spontaneous recovery is rare. Rehabilitation approaches include restorative treatments, which a…
Phase: NA • Sponsor: Istituto Auxologico Italiano • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Promising drug cocktail targets Hard-to-Treat cervical cancer
Disease control Not yet recruitingThis is a Phase II clinical trial to evaluate the safety and efficacy of Utidelone, a genetically engineered epothilone derivative, combined with Toripalimab, a PD-1 inhibitor, in patients with recurrent or metastatic cervical cancer who have progressed after standard treatments.…
Phase: PHASE2 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Heart shield: common drug may prevent Chemo-Induced cardiac harm
Prevention Not yet recruitingThis study aims to evaluate the efficacy and safety of telmisartan as a cardioprotective agent in patients receiving doxorubicin-based chemotherapy, with the goal of reducing treatment-associated cardiotoxicity, optimizing therapeutic outcomes, and facilitating the safer administ…
Phase: PHASE1, PHASE2 • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Laser zaps stent blockages better than balloons?
Disease control Not yet recruitingStent restenosis (ISR) is an increasingly common problem; in fact, approximately 10% of coronary angioplasty procedures involve the treatment of a previously implanted stent. In cases of ISR of drug-eluting stents, the rate of further restenosis remains high (approximately 13% at…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Hypnosis and VR tested to calm leukemia Patients' fears
Symptom relief Not yet recruitingThis is a pilot study comparing 3 arms (standard care with hypnosis / standard care with virtual reality / standard care alone), aimed at measuring the effect on anxiety during the induction treatment. Acute myeloid leukemia is considered an oncological emergency that requires ch…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New drug may help kids with kidney disease avoid relapses
Disease control Not yet recruitingThis is an open-label randomized controlled trial to evaluate the efficacy and safety of one dose versus two doses of ripertamab in children with frequent relapses or steroid-dependent nephrotic syndrome (FRNS/SDNS).
Phase: NA • Sponsor: Mao Jianhua • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug combo aims to shrink Hard-to-Treat throat cancer
Disease control Not yet recruitingThis study aims to explore the efficacy and safety of scipibaimab combined with tislelizumab in patients with recurrent or metastatic nasopharyngeal carcinoma who have progressed after first-line therapy.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Brain zaps may ease Parkinson's movement problems
Symptom relief Not yet recruitingDopaminergic medications and Deep Brain Stimulation (DBS) are the current standards interventions for Parkinson's Disease. Pharmacotherapy with dopaminergic drugs leads to partial improvement in motor functions of patients. Invasive therapies like DBS have as yet limited availabi…
Phase: PHASE3 • Sponsor: Dr. Ram Manohar Lohia Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Gut bacteria pill could turn back the clock on aging
Disease control Recruiting nowThis study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores…
Phase: NA • Sponsor: Synbiotic Health • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Zapping the brain to heal the liver: new trial tests TMS for fatty liver
Disease control Not yet recruitingThe goal of this clinical trial is to learn if repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive brain stimulation technique, works to treat Metabolic dysfunction-associated and alcohol-associated liver disease (MetALD). The main questions it aims to answer are:…
Phase: NA • Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo therapy aims to boost bladder cancer treatment before surgery
Disease control Not yet recruitingIn this study, the relevant biomarkers for predicting the efficacy of neoadjuvant therapy in patients with MIBC were further explored. Meanwhile, the dynamic molecular monitoring of neoadjuvant therapy in MIBC patients and the treatment guidance based on the MHC tumor immune micr…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Gene therapy shot around the eye aims to reduce bulging in thyroid eye disease
Disease control Not yet recruitingThe goal of this study is to evaluate the safety, tolerability, and efficacy of KRIYA-586 (VV-14305) in treating thyroid eye disease (TED).
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for Hard-to-Treat seizures: cenobamate under study
Disease control ENROLLING_BY_INVITATIONOver the last decades, multiple neuronal autoantibodies directed against intracellular or cell-surface antigens have been identified in association with epilepsy and encephalopathy. In some patients with immune-mediated brain disorders, seizures persist and become chronic despite…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New lens design aims to halt worsening eyesight in children
Disease control ENROLLING_BY_INVITATIONEvaluate the effectiveness of different lithographic microstructured myopia management lenses in controlling the progression of myopia in children and adolescents, as well as the safety and comfort of wearing them. Explore effective defocus microlens designs for myopia control an…
Phase: NA • Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New endoscopic drainage may spare elderly patients from gallbladder surgery
Disease control Recruiting nowAcute cholecystitis is common in elderly patients and becomes more frequent with increasing age. Standard treatment is laparoscopic cholecystectomy (LCC), but operative treatment may be associated with increased risk in older patients with substantial comorbidity or reduced toler…
Phase: NA • Sponsor: Oulu University Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a safer dose of an old drug shield vulnerable children from deadly fungal infections?
Disease control Recruiting nowThis is a single-center, single-arm, observational clinical study evaluating the efficacy and safety of low-dose liposomal amphotericin B (1 mg/kg/day, intravenous, once daily) for the prevention of invasive fungal infections in children aged 3-17 years with hematological maligna…
Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC